Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2

J Orthop Res. 2011 Nov;29(11):1745-52. doi: 10.1002/jor.21439. Epub 2011 Apr 15.

Abstract

An ideal artificial substitute has good biocompatibility properties and is able to provide for rapid bone formation. Bone morphogenetic protein-2 (BMP-2) is considered as one of the most important growth factors for bone regeneration. In this study, a synthetic BMP-2-related peptide (designated P24) corresponding to residues of the knuckle epitope of BMP-2 was introduced into a bioactive scaffold based on nano-hydroxyapatite/collagen/poly(L-lactic acid) (nHAC/PLLA); its in vitro release kinetics was then measured. A 5 mm diameter cranial bone defect was created in the calvariae of 30 rats and randomly implanted with three groups of biomaterials: Group A (nHAC/PLLA alone); Group B (P24/nHAC/PLLA composite); and Group C (recombinant human BMP-2 (rhBMP-2)/nHAC/PLLA composite). The P24/nHAC/PLLA implants significantly stimulated bone growth similarly to the rhBMP-2/nHAC/PLLA implants based on the radiographic and three-dimensional CT evaluation and histological examination, thereby confirming the enhanced bone healing rate of these compounds compared with the stand-alone nHAC/PLLA scaffold material. The osteoinductive ability of 3 mg P24 was similar to that of 1 µg rhBMP-2. P24/nHAC/PLLA is a promising scaffold biomaterial for bone tissue regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Diseases / diagnostic imaging
  • Bone Diseases / drug therapy*
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Bone Regeneration / drug effects*
  • Bone Regeneration / physiology
  • Collagen / pharmacology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Durapatite / pharmacology*
  • Humans
  • Lactic Acid / pharmacology*
  • Male
  • Peptides / pharmacology
  • Polyesters
  • Polymers / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology
  • Skull / diagnostic imaging
  • Skull / drug effects*
  • Skull / physiology
  • Tissue Scaffolds
  • Tomography, X-Ray Computed
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Bone Morphogenetic Protein 2
  • Peptides
  • Polyesters
  • Polymers
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • nano-hydroxyapatite-collagen
  • recombinant human bone morphogenetic protein-2
  • Lactic Acid
  • poly(lactide)
  • Collagen
  • Durapatite